Cargando…

Case report: Savolitinib induced severe adverse reactions resembling septic shock in an HIV-1–positive patient with advanced non-small cell lung cancer

Savolitinib, a small-molecule inhibitor of the receptor tyrosine kinase mesenchymal-epithelial transition (MET) factor, was approved for the treatment of non-small cell lung cancer (NSCLC) by the China National Medical Products Administration in June 2021. Its safety for NSCLC treatment has been con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Ye, Cao, Qing, Guo, Yongzheng, Liu, Xiang, Zhu, Xueling, Dai, Bohao, Zhu, Biao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932794/ https://www.ncbi.nlm.nih.gov/pubmed/36817157 http://dx.doi.org/10.3389/fphar.2023.1089184

Ejemplares similares

HIV-associated dyslipidemia: pathogenesis and its management
por: Wan, Zhikai, et al.
Publicado: (2023)

Savolitinib: A Promising Targeting Agent for Cancer
por: Lee, Tae Seung, et al.
Publicado: (2023)

Savolitinib versus crizotinib for treating MET positive non‐small cell lung cancer
por: Miao, Kang, et al.
Publicado: (2023)

Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock
por: Borsuk-De Moor, Agnieszka, et al.
Publicado: (2018)

Are Corticosteroids Beneficial for Sepsis and Septic Shock? Based on Pooling Analysis of 16 Studies
por: Yao, Yang-Yang, et al.
Publicado: (2019)

Terlipressin Versus Norepinephrine for Septic Shock: A Systematic Review and Meta-Analysis
por: Huang, Po, et al.
Publicado: (2019)

Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
por: Li, Dongxuan, et al.
Publicado: (2023)

Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and Savolitinib
por: Lim, Sun Min, et al.
Publicado: (2021)

Clinical Efficiency of Vasopressin or Its Analogs in Comparison With Catecholamines Alone on Patients With Septic Shock: A Systematic Review and Meta-Analysis
por: Yao, Ren-qi, et al.
Publicado: (2020)

Remifentanil for Carboprost-Induced Adverse Reactions During Cesarean Delivery Under Combined Spinal-Epidural Anesthesia
por: Wei, Chang-na, et al.
Publicado: (2020)

Influence of continuous renal replacement therapy on the plasma concentration of tigecycline in patients with septic shock: A prospective observational study
por: Huang, Fang, et al.
Publicado: (2023)

Effects of combination therapy with Shenfu Injection in critically ill patients with septic shock receiving mechanical ventilation: A multicentric, real-world study
por: Li, Xiaoqian, et al.
Publicado: (2022)

Pharmacogenomics and adverse drug reactions in children
por: Rieder, Michael J., et al.
Publicado: (2014)

Dihydrotanshinone I Specifically Inhibits NLRP3 Inflammasome Activation and Protects Against Septic Shock In Vivo
por: Wei, Ziying, et al.
Publicado: (2021)

The Efficacy and Safety of Esmolol for Septic Shock: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Huang, Po, et al.
Publicado: (2021)

Efficacy and Safety of Neostigmine Adjunctive Therapy in Patients With Sepsis or Septic Shock: A Randomized Controlled Trial
por: El-Tamalawy, Mona M., et al.
Publicado: (2022)

Research on named entity recognition of adverse drug reactions based on NLP and deep learning
por: Wei, Jianxiang, et al.
Publicado: (2023)

Multisystem organ failure secondary to acute generalised exanthematous pustulosis (AGEP) with atypical presentation resembling septic shock
por: Cravero, Karen, et al.
Publicado: (2022)

Landscape of Savolitinib Development for the Treatment of Non-Small Cell Lung Cancer with MET Alteration—A Narrative Review
por: Zhu, Xiaokuan, et al.
Publicado: (2022)

Renal adverse reactions of tyrosine kinase inhibitors in the treatment of tumours: A Bayesian network meta-analysis
por: Xiong, Ying, et al.
Publicado: (2022)

Comparison of Adverse Reactions Caused by Olaparib for Different Indications
por: Zhou, Yujing, et al.
Publicado: (2022)

Comparative Efficacy of Chinese Herbal Injections for Septic Shock: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
por: Huang, Peiying, et al.
Publicado: (2022)

ALDH2 attenuates myocardial pyroptosis through breaking down Mitochondrion-NLRP3 inflammasome pathway in septic shock
por: Zhang, Ying, et al.
Publicado: (2023)

The Impact of Plasma Protein Binding Characteristics and Unbound Concentration of Voriconazole on Its Adverse Drug Reactions
por: Yuan, Zi-Qing-Yun, et al.
Publicado: (2020)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Adverse Drug Reactions in Pediatric Oncohematology: A Systematic Review
por: Amaro-Hosey, Kristopher, et al.
Publicado: (2022)

Pharmacists’ experiences on adverse drug reaction: 10 years later
por: Karuppannan, Mahmathi, et al.
Publicado: (2022)

Adverse drug reactions in an ageing PopulaTion (ADAPT) study: Prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients
por: Cahir, Caitriona, et al.
Publicado: (2023)

Dramatic response and acquired resistance to savolitinib in advanced intrahepatic cholangiocarcinoma with MET amplification: a case report and literature review
por: Zhou, Kexun, et al.
Publicado: (2023)

Adjunctive granisetron therapy in patients with sepsis or septic shock (GRANTISS): A single-center, single-blinded, randomized, controlled clinical trial
por: Guan, Jianbin, et al.
Publicado: (2022)

Association between Medication Adherence Outcomes and Adverse Drug Reactions to Highly Active Antiretroviral Therapy in Indian Human Immunodeficiency Virus-Positive Patients
por: Rajesh, R, et al.
Publicado: (2012)

Lenalidomide potentially reduced the level of cell- associated HIV RNA and improved persistent inflammation in patients with HIV-associated cryptococcal meningitis a pilot study
por: Liu, Xiang, et al.
Publicado: (2022)

Reported Adverse Drug Reactions in Infants: A Nationwide Analysis in Malaysia
por: Rosli, Rosliana, et al.
Publicado: (2017)

Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine
por: Micaglio, Emanuele, et al.
Publicado: (2021)

Adverse Reactions to Drugs of Special Interest in a Pediatric Oncohematology Service
por: Amaro-Hosey, Kristopher, et al.
Publicado: (2021)

Adverse Drug Reactions Caused by Antimicrobials Treatment for Ventilator-Associated Pneumonia
por: Shen, Shan, et al.
Publicado: (2022)

The pharmacogenomics of carbamazepine-induced cutaneous adverse drug reaction in the South of Vietnam
por: Nguyen, Ai-Hoc, et al.
Publicado: (2023)

Descriptions of Adverse Drug Reactions Are Less Informative in Forums Than in the French Pharmacovigilance Database but Provide More Unexpected Reactions
por: Karapetiantz, Pierre, et al.
Publicado: (2018)

Model Based Evaluation of Hypersensitivity Adverse Drug Reactions to Antimicrobial Agents in Children
por: Elzagallaai, Abdelbaset A., et al.
Publicado: (2021)

The pathogenesis, diagnosis, prevention, and treatment of CAR-T cell therapy-related adverse reactions
por: Li, Yanping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_otnog5b21tfiqj3k1p1e7nndoc